Patents for C07D 277 - Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings (33,621) |
---|
03/08/2006 | EP1451167B1 Phenylalkynes |
03/08/2006 | EP1446393B1 2-amino-thiazoline derivatives and their use as inhibitors of inducible no-synthase |
03/08/2006 | EP1339723B1 Process and ester derivatives useful for preparation of cephalosporins |
03/08/2006 | EP1325009B1 Amino-substituted tetracyclic compounds useful as anti-inflammatory agents and pharmaceutical compositions comprising same |
03/08/2006 | EP1313721B1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
03/08/2006 | CN1745067A Biphenylcarboxamide compound |
03/08/2006 | CN1743321A Method for preparing thiazolidine acetate coprising phenyl propylidene |
03/08/2006 | CN1244575C Sulfonyl alkylamido hydroxyethylamino sulfonamide retroviral protease inhibitors |
03/08/2006 | CN1244542C Aromatic amine derivatives having NOS inhibitory effect |
03/07/2006 | US7008957 6-amino-5-oxo--hexahydropyrrolo[2,1-b]thiazole-3-carbonitrile compounds of given formula; for the treatment of metabohlic disorders such as type 2 diabetes |
03/07/2006 | US7008956 p53 inhibitors and therapeutic use of the same |
03/07/2006 | US7008753 Optical recording medium |
03/07/2006 | US7008561 Ether carboxylic acids based on alkoxylated mercaptobenzothiazoles and use of the same as corrosion inhibitors |
03/02/2006 | WO2006023720A2 Reactions of enolizable a-amino aldehydes or ketones to form amine |
03/02/2006 | WO2006022442A1 Novel heterocyclic amide derivatives having dihydroorotate dehydrogenase inhibiting activity |
03/02/2006 | WO2006022252A1 Method for producing aminothiazole derivative and production intermediate |
03/02/2006 | WO2006021806A1 Arylsulphonylstilbene derivatives for treatment of insomnia and related conditions |
03/02/2006 | WO2006021805A1 Diarylsulfones as 5-ht2a antagonists |
03/02/2006 | WO2005113542A3 N-cyclic sulfonamido inhibitors of gamma secretase |
03/02/2006 | WO2005072132A3 TRICYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF |
03/02/2006 | US20060047123 Mercaptoamides as histone deacetylase inhibitors |
03/02/2006 | DE102004041532A1 Biphenylthiazolcarboxamide Biphenyl thiazole carboxamides |
03/02/2006 | DE102004041530A1 Biphenylthiazolcarboxamide Biphenyl thiazole carboxamides |
03/02/2006 | CA2838123A1 Method for producing aminothiazole derivative and production intermediate |
03/02/2006 | CA2577846A1 Thiazolo-naphthyl acids as inhibitors of plasminogen activator inhibitor-1 |
03/02/2006 | CA2577837A1 Diarylsulfones as 5-ht2a antagonists |
03/02/2006 | CA2576469A1 Method for producing aminothiazole derivative and production intermediate |
03/01/2006 | EP1630157A1 CaSR ANTAGONIST |
03/01/2006 | EP1630152A1 Condensed ring compound |
03/01/2006 | EP1629842A1 Topical application of thiazolyl amides |
03/01/2006 | EP1628687A2 Releasable polymeric conjugates based on aliphatic biodegradable linkers |
03/01/2006 | EP1628666A2 Compouds and uses thereof in modulating amyloid beta |
03/01/2006 | EP1628662A1 Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine a2a receptor |
03/01/2006 | EP1628661A2 Modulators of vr1 receptor |
03/01/2006 | EP1462451B1 Novel crystalline forms of meloxicam and the preparation and interconversion methods thereof |
03/01/2006 | EP1347971B1 Thiazolyl inhibitors of tec family tyrosine kinases |
03/01/2006 | EP1324774B1 Use of a ppar delta activator for treating inflammatory conditions |
03/01/2006 | EP1098638B1 Use of a glucose uptake enhancer for reducing post-ischemic injury of the heart |
03/01/2006 | EP1017382B1 Biarylalkanoic acids as cell adhesion inhibitors |
03/01/2006 | CN1742010A Novel chemical compounds |
03/01/2006 | CN1741802A Propargyl-trifluoromethoxy-amino-benzothiazole derivatives |
03/01/2006 | CN1243741C Quinolinyl and benzothiazolyc PPAR-gamma modulators |
03/01/2006 | CN1243740C Alpha-form or beta-form crystal of acetanilide derivative |
03/01/2006 | CN1243739C Method for production of 1,3-disubstituted 2-nitroguanidines |
03/01/2006 | CN1243724C Amide derivatives which are useful as cell factor inhibitors |
03/01/2006 | CN1243545C DNA-cleaving antitumor agents |
02/28/2006 | US7005538 N-[3,5-Dibromo-4-(3-bromobenzyloxy)benzoyl]benzenesulphonamide for example; use to treat cardiac arrhythmias, thyrotoxicosis and subclinical hyperthyroidism |
02/28/2006 | US7005440 Therapeutic uses of tri-aryl acid derivatives |
02/23/2006 | WO2005110980A3 Aryl sulfones and uses related thereto |
02/23/2006 | WO2005048953A3 Amide derivatives as kinase modulators |
02/23/2006 | US20060040998 Thiazolidinone amides, thiazolidine carboxylic acid amides, methods of making, and uses thereof |
02/23/2006 | US20060040997 Benzthiazole-3 oxides useful for the treatment of proliferative disorders |
02/23/2006 | US20060040996 Administering compound such as 5 {[2-(dimethylamino)ethyl]amino}-2-methyl-1,3-benzothiazole-4,7-dione |
02/23/2006 | US20060040992 Antiinflammatory 3-arylthio-3-thiazolyl-alkylamines |
02/23/2006 | CA2576388A1 Methods and compositions for modulating sphingosine-1-phosphate (s1p) receptor activity |
02/23/2006 | CA2575466A1 Thiazole based inhibitors of atp-utilizing enzymes |
02/23/2006 | CA2574279A1 Heterocyclic compounds as pharmaceutical agents |
02/23/2006 | CA2573772A1 Heterocyclyls as selective melanin concentrating hormone receptor antagonists for the treatment of obesity and related disorders |
02/22/2006 | EP1627869A1 Amide derivative |
02/22/2006 | EP1627635A2 Benzothiazolium compounds for use in methods of inhibiting NO production and TNF alpha and treating coronaviral infection |
02/22/2006 | EP1626962A1 Benzamide inhibitors of the p2x7 receptor |
02/22/2006 | CN1738808A Cyclization process for substituted benzothiazole derivatives |
02/22/2006 | CN1738799A Methods for preparing phenylalkyne derivatives |
02/22/2006 | CN1738797A Substituted aryl thioureas and related compounds; inhibitors of viral replication |
02/22/2006 | CN1242998C Process of recovering 2-mercaptan benzothiazole from cefotaxime producing slag |
02/21/2006 | US7002036 For production of (poly)peptides; comprises Michael-type addition of nucleophile to a dialkyl 2-methylidenylpropan-1,3-dioate and conversion of ester to amino moiety |
02/21/2006 | US7002019 aryl hydrocarbon; oxidation of 4,5-dihydro-1,3-azoles to fully unsaturated ring; heterocyclic ketones |
02/21/2006 | US7001916 Epothilon derivatives, method for the production and the use thereof as pharmaceuticals |
02/21/2006 | US7001909 For therapy of cardiovascular diseases such as atrial and ventricular arrhythmias, intermittent claudication, Prinzmetal's (variant) angina, stable and unstable angina, exercise induced angina, congestive heart disease |
02/21/2006 | US7001907 Peptide-containing α-ketoamide cysteine and serine protease inhibitors |
02/21/2006 | CA2337846C Polymorph of ritonavir |
02/16/2006 | WO2006016218A1 Aryl or heteroaryl carbonyl derivatives derivatives useful as vanilloid receptor 1 (vr1) antagonists |
02/16/2006 | WO2006016174A1 Fluorination process of protected aminothiazole |
02/16/2006 | WO2006016039A1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
02/16/2006 | WO2006015859A1 Trifluoromethyl substituted benzamides as kinase inhibitors |
02/16/2006 | WO2005080317A3 Therapeutic amide derivatives |
02/16/2006 | WO2005055941A3 Novel m3 muscarinic acetylcholine receptor antagonists |
02/16/2006 | US20060035946 Amyloid-binding, metal-chelating agents |
02/16/2006 | US20060035899 Use of cysteine derivatives for the preparation of a medicament intended to treat pathologies which result from the formation of the heterotrimeric G protein |
02/16/2006 | US20060035897 Trifluoromethyl substituted benzamides as kinase inhibitors |
02/16/2006 | US20060035884 N-cyclic sulfonamido inhibitors of gamma secretase |
02/16/2006 | CA2575430A1 1,3-disubstituted heteroaryl nmda/nr2b antagonists |
02/16/2006 | CA2575316A1 Trifluoromethyl substituted benzamides as kinase inhibitors |
02/16/2006 | CA2573509A1 Histone deacetylase inhibitors |
02/16/2006 | CA2571143A1 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
02/15/2006 | EP1625122A1 Dipeptidyl peptidase inhibitors |
02/15/2006 | EP1625112A1 Novel compounds for treatment of obesity |
02/15/2006 | CN1735604A Process for preparing 2,6-diamino-4,5,6,7-tetrahydro-benzothiazole |
02/15/2006 | CN1735598A Phenyl or heteroaryl amino alkane derivatives as IP receptor antagonist |
02/15/2006 | CN1733722A Bis-heterocyclic compounds with antitumour and chemosensitising activity |
02/15/2006 | CN1733699A Quaternary bis-ammonium salt precursors and their uses as prodrugs having an antiparasitic activity |
02/14/2006 | US6998487 Structure including at least three planar moieties, which are linearly configured such that one planar moiety is located between two neighboring planar moieties and shares an atom with each of the moieties |
02/14/2006 | US6998423 Sulfonyl-amino or carbonyl-amino derivatives; osteoporosis bone disorders; therapeutic drug or kits including anti-resorptive agents, anabolic agents; |
02/14/2006 | US6998412 Heterocyclic compounds |
02/14/2006 | US6998409 Drugs for treating chronic pain; stereoisomers; chemical synthesis from intermediates; nontoxic |
02/14/2006 | US6997961 N-heteroarylmethyl-m-phenylenediamine derivatives-containing dyes for keratin fibers and novel n-heteroarylmethyl-m-phenylenediamine derivatives |
02/09/2006 | WO2006013445A2 Thiazolidinedione derivatives as alpha adrenergic receptor antagonists |
02/09/2006 | US20060030713 N-phenylarylsulfonamide compound, pharmaceutical composition comprising the compound as active ingredient, synthetic intermediate for the compound and process for its preparation |
02/09/2006 | US20060030709 PNA monomer and precursor |
02/09/2006 | US20060030657 Use of sulfur containing initiators for anionic polymerization of monomers |